norgestrel has been researched along with Arteriosclerosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knopp, RH; Leboeuf, RC; Rosenfeld, ME; Shultz, JM; Zhu, XD | 1 |
| Crona, N; Samsioe, G; Silfverstolpe, G | 1 |
| Letterie, GS | 1 |
| Danzinger, RG; Koh, KS | 1 |
| Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M | 1 |
| Adams, MR; Clarkson, TB; Koritnik, DR; Nash, HA | 1 |
1 trial(s) available for norgestrel and Arteriosclerosis
| Article | Year |
|---|---|
Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation | 1987 |
6 other study(ies) available for norgestrel and Arteriosclerosis
| Article | Year |
|---|---|
Norgestrel, increased lipids: fact or "marketing monster"?
Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases | 1989 |
Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice.
Topics: Adipose Tissue; Animals; Apolipoproteins E; Arteriosclerosis; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Estradiol; Female; Insulin; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Norgestrel; Organ Size; Ovariectomy; Random Allocation; Sinus of Valsalva | 2004 |
Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins; Arteriosclerosis; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1984 |
Impact of subdermal norgestrel on hepatic acyl-coenzyme A:cholesterol- acyltransferase (ACAT) activity: possible antiatherogenic effect.
Topics: Administration, Cutaneous; Animals; Arteriosclerosis; Cholesterol; Ethinyl Estradiol; Female; Liver; Norgestrel; Rats; Rats, Sprague-Dawley; Sterol O-Acyltransferase; Weight Loss | 2000 |
Massive intestinal infarction in young women: complication of use of oral contraceptives?
Topics: Abdomen, Acute; Adult; Arteriosclerosis; Celiac Artery; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Iliac Artery; Infarction; Intestines; Lynestrenol; Mesenteric Vascular Occlusion; Mestranol; Norethindrone; Norethynodrel; Norgestrel; Smoking; Thromboembolism; Time Factors | 1977 |
Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques.
Topics: Animals; Arteriosclerosis; Blood Pressure; Cholesterol, HDL; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Coronary Artery Disease; Estradiol; Female; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, HDL2; Macaca fascicularis; Male; Norgestrel | 1987 |